Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
Clinical trial NCT02851056 · COMPLETED
Trial details
- NCT number
- NCT02851056
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-27
- Primary completion
- 2018-07-16
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.